share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 21 00:08
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 480 shares of common stock on 02/20/2024, with an aggregate market value of $201,979.20. The shares to be sold were recently acquired on 02/17/2024, as part of compensation in the form of 240 performance shares and 240 shares from restricted stock vesting, both issued by the company. This transaction follows a previous sale of 314 shares by Tatsis in the past three months, which grossed $131,955.36. The notice for the upcoming sale was filed on the same day as the planned sale, with the instruction for this transaction having been adopted on 05/09/2023.
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 480 shares of common stock on 02/20/2024, with an aggregate market value of $201,979.20. The shares to be sold were recently acquired on 02/17/2024, as part of compensation in the form of 240 performance shares and 240 shares from restricted stock vesting, both issued by the company. This transaction follows a previous sale of 314 shares by Tatsis in the past three months, which grossed $131,955.36. The notice for the upcoming sale was filed on the same day as the planned sale, with the instruction for this transaction having been adopted on 05/09/2023.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.